Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus-Reference-Cited by-同舟云学术

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus

Published:2020-04-22 Issue:6 Volume:4 Page:916-931
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Menne Stephan¹,Wildum Steffen²,Steiner Guido²,Suresh Manasa¹,Korolowicz Kyle¹,Balarezo Maria¹,Yon Changsuek¹,Murreddu Marta¹,Hong Xupeng¹,Kallakury Bhaskar V.³,Tucker Robin⁴,Yang Song⁵,Young John A.T.²,Javanbakht Hassan²

Affiliation:

1. Department of Microbiology and Immunology Georgetown University Medical Center Washington DC

2. Roche Pharma Research and Early Development Roche Innovation Center Basel Basel Switzerland

3. Department of Pathology Georgetown University Medical Center Washington DC

4. Department of Pharmacology Georgetown University Medical Center Washington DC

5. Roche Pharma Research and Early Development Roche Innovation Center Shanghai Shanghai China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1502

Reference49 articles.

1. A global scientific strategy to cure hepatitis B

2. Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials

3. Hepatitis B therapy

4. How chronic viral infections impact on antigen-specific T-cell responses

5. Effective intrahepatic CD8+ T-cell immune responses are induced by low but not high numbers of antigen-expressing hepatocytes

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters;Viruses;2024-04-16

2. “PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro;Bioorganic & Medicinal Chemistry Letters;2024-04

3. Discovery of Hepatitis B Virus Surface Antigen Suppressor GS-8873;ACS Medicinal Chemistry Letters;2024-03-22

4. Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161;Viruses;2024-02-21

5. Unexpected neurotoxicity in chronic toxicity studies with a HBV viral expression inhibitor;Regulatory Toxicology and Pharmacology;2023-06